DexCom had 11 patents in digitalization during Q2 2024. DexCom Inc filed patents in Q2 2024 for systems and methods that generate graphical displays of analyte data and health information. These displays are based on a self-referential dataset that can be modified to indicate features in the analyte data of a host. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom had no grants in digitalization as a theme in Q2 2024.
Recent Patents
Application: Systems and methods for health data visualization and user support tools for continuous glucose monitoring (Patent ID: US20240197264A1)
The patent filed by DexCom Inc. discloses systems and methods for generating graphical displays of analyte data and health information. These graphical displays are based on a self-referential dataset that can be modified based on identified portions of the data to indicate features in the analyte data of a host. The patent includes claims related to an analyte monitoring system comprising a continuous analyte sensor, sensor electronics module, and display devices like a smartwatch and smartphone for generating visual representations of the analyte data.
The system allows for the direct transmission of analyte data from the sensor electronics module to the first and second display devices, each generating graphical user interfaces to display visual representations of the data. The patent also covers variations in the content and format of the data packages transmitted to the display devices, as well as the sequential or simultaneous generation of alarms based on the analyte data. Additionally, the method outlined in the patent involves measuring the analyte concentration, generating analyte data, and transmitting it to the display devices, with the option for additional processing of the data by the devices to create visual representations. The method also includes provisions for communication attempts with the display devices in a predetermined order and the generation of alarms based on the analyte data.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
